Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on May 28, 2025
Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025
GlobeNewswire
·
May 28, 2025
MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials and Materials Conference on June 11 …
OTC Markets Group Welcomes Magna Mining Inc. to OTCQX
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced that Magna Mining Inc. (TSX-V: NICU; OTCQX: MGMNF), a company engaged in …
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting
GlobeNewswire
·
May 28, 2025
90 mg once-daily palazestrant dose selected for Part 2 of the Phase 3 OPERA-01 monotherapy trial and for the Phase 3 OPERA-02 combination trial with ribociclib OPERA-01 trial-in-progress poster to be presented on Monday, June 2 between 9:00am–12:00pm CT / …
Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that its management team is scheduled …
Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
GlobeNewswire
·
May 28, 2025
– Company on track to begin ELEVATE-45-201 in Q3 2025 – – Follows recently received Medicines and Healthcare Products Regulatory Agency authorization in the United Kingdom for ELEVATE-45-201 – BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, …
Photronics Reports Second Quarter Fiscal 2025 Results and Announces CEO Transition
GlobeNewswire
·
May 28, 2025
BROOKFIELD, Conn., May 28, 2025 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its second quarter of fiscal year 2025 ended May 4, 2025 and also announced …
Churchill Very Pleased to Report High Grade Antimony >10%Sb, and Gold >10g/t Au at Black Raven Past-Producers, NL
GlobeNewswire
·
May 28, 2025
TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Churchill Resources Inc. ("Churchill") is extremely pleased to announce that due-diligence sampling at the historical Frost Cove Antimony and Stewart Gold mines on the Black Raven property returned assays of >10% …
NASA Visits Constellium Ravenswood to Celebrate Artemis Partnership
GlobeNewswire
·
May 28, 2025
PARIS, May 28, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) is honored to welcome NASA representatives to its Ravenswood, West Virginia facility today to celebrate their collaboration on the Artemis program — NASA’s bold mission to return humans to …
Harfang intercepte 4,5 g/t Au sur 15,6 m et délimite un nouvel axe minéralisé à haute teneur à Sky Lake, Ontario
GlobeNewswire
·
May 28, 2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (« Harfang » ou la « Société ») a le plaisir d’annoncer des intersections aurifères additionnelles à haute teneur ainsi que les derniers résultats de son programme inaugural de …
BioStem Announces Notice of Allowance for Three New U.S. Patent Applications
GlobeNewswire
·
May 28, 2025
POMPANO BEACH, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that …
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
Monte Rosa Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that Markus Warmuth, M.D., Chief Executive Officer …
Harfang Intersects 4.5 g/t Au Over 15.6 m and Delineates New High-Grade Mineralized Shoot at Sky Lake, Ontario
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” or the “Company”) is pleased to announce additional high-grade intercepts and the second batch of results from the 2025 winter diamond drill program (“Winter …
Axsome Therapeutics Presents Data from Three of Its Innovative Neuroscience Programs at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
GlobeNewswire
·
May 28, 2025
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced presentations from three of its innovative …
DAVIDsTEA Delivers Strong Turnaround in Fourth Quarter and Full Year Fiscal 2024 Results
GlobeNewswire
·
May 28, 2025
Fiscal 2024 Sales reached $61.8 million, up 2% year-over-year Net loss narrows to $3.2 million, a $10.6 million improvement Adjusted EBITDA turned positive at $3.9 million, up $9.3 million Free cash flow of $7.3 million with year cash of $16.2 Q4 2024 …
Les Thés DAVIDsTEA annoncent un solide redressement dans leurs résultats du quatrième trimestre et de l'exercice financier 2024
GlobeNewswire
·
May 28, 2025
Exercice 2024 Ventes de 61,8 M$, soit une augmentation de 2 % par rapport à l'exercice précédent. La perte nette limitée à 3,2 M$, soit une amélioration de 10,6 M$. Le BAIIA ajusté est devenu positif à 3,9 M$, soit une augmentation de 9,3 M$. Le flux de …
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SAN FRANCISCO, May 28, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …
Sono-Tek Reports Strong Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 28, 2025
-Reports Fourth Consecutive Quarter of Revenue above $5 million -FY 2025 Revenue Growth of 4% YOY - Backlog Remains Strong at $8.6 Million - Projecting Continued Revenue Growth and Profitability in the First Half of Fiscal Year 2026 -Conference Today at 11 …
Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration
GlobeNewswire
·
May 28, 2025
Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial …
Worksport Secures ISO 9001 Certification at U.S. Factory, Unlocking Revenue & OEM Growth Pathways
GlobeNewswire
·
May 28, 2025
Prestigious Global Certification Expected to Accelerate Strategic Supply Relationships with Major Auto OEMs and Distributors West Seneca, New York, May 28, 2025 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based …